Financhill
Buy
64

MELI Quote, Financials, Valuation and Earnings

Last price:
$2,049.05
Seasonality move :
10.38%
Day range:
$2,043.55 - $2,109.34
52-week range:
$1,324.99 - $2,374.54
Dividend yield:
0%
P/E ratio:
54.33x
P/S ratio:
5.00x
P/B ratio:
23.86x
Volume:
326.9K
Avg. volume:
485.6K
1-year change:
35.46%
Market cap:
$103.8B
Revenue:
$20.8B
EPS (TTM):
$37.70
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4B $7.1B $10.8B $15.1B $20.8B
Revenue Growth (YoY) 73.06% 77.88% 52.5% 40.14% 37.53%
 
Cost of Revenues $2.3B $4.1B $5.6B $7.5B $11.2B
Gross Profit $1.7B $3B $5.2B $7.6B $9.6B
Gross Profit Margin 43.01% 42.51% 48.22% 50.24% 46.09%
 
R&D Expenses $353M $590M $1.1B $1.8B $1.9B
Selling, General & Admin $1.1B $1.5B $2B $2.5B $3.2B
Other Inc / (Exp) -$43M -$109M -$198M -$615M -$182M
Operating Expenses $1.6B $2.6B $4.1B $5.4B $6.9B
Operating Income $128M $441M $1.1B $2.2B $2.6B
 
Net Interest Expenses $4M $91M $91M $39M $17M
EBT. Incl. Unusual Items $81M $241M $780M $1.6B $2.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $82M $149M $298M $569M $521M
Net Income to Company -$1M $83M $482M $987M $1.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1M $83M $482M $987M $1.9B
 
Basic EPS (Cont. Ops) -$0.08 $1.67 $9.57 $19.64 $37.69
Diluted EPS (Cont. Ops) -$0.08 $1.67 $9.53 $19.46 $37.69
Weighted Average Basic Share $49.7M $49.8M $50.3M $50.3M $50.7M
Weighted Average Diluted Share $49.7M $49.8M $51.3M $51M $50.7M
 
EBITDA $293M $674M $1.3B $2.3B $3.2B
EBIT $188M $470M $915M $1.7B $2.6B
 
Revenue (Reported) $4B $7.1B $10.8B $15.1B $20.8B
Operating Income (Reported) $128M $441M $1.1B $2.2B $2.6B
Operating Income (Adjusted) $188M $470M $915M $1.7B $2.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1.3B $2.1B $3.2B $4.4B $6.1B
Revenue Growth (YoY) 96.93% 60.41% 52.35% 35.87% 37.42%
 
Cost of Revenues $839M $1.3B $1.8B $2.4B $3.3B
Gross Profit $488.8M $853M $1.5B $2.1B $2.7B
Gross Profit Margin 36.81% 40.05% 46.01% 46.5% 45.37%
 
R&D Expenses $117.5M $179M $325M $686M $512M
Selling, General & Admin $263.1M $486M $556M $730M $890M
Other Inc / (Exp) -$10.5M -$57M -$64M -$107M -$50M
Operating Expenses $513.6M $829M $1.1B $1.7B $1.9B
Operating Income -$24.8M $24M $384M $335M $820M
 
Net Interest Expenses $9M -- $12M -- $7M
EBT. Incl. Unusual Items -$44.3M -$33M $308M $230M $763M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $6.5M $4M $144M $65M $124M
Net Income to Company -$50.9M -$46M $165M $165M $639M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$50.9M -$46M $165M $165M $639M
 
Basic EPS (Cont. Ops) -$1.02 -$0.92 $3.28 $3.26 $12.61
Diluted EPS (Cont. Ops) -$1.02 -$0.92 $3.25 $3.25 $12.61
Weighted Average Basic Share $49.8M $49.9M $50.3M $50.6M $50.7M
Weighted Average Diluted Share $49.8M $49.9M $51.3M $53M $50.7M
 
EBITDA $20.2M $88M $344M $403M $963M
EBIT -$12.4M $21M $222M $268M $811M
 
Revenue (Reported) $1.3B $2.1B $3.2B $4.4B $6.1B
Operating Income (Reported) -$24.8M $24M $384M $335M $820M
Operating Income (Adjusted) -$12.4M $21M $222M $268M $811M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4B $7.1B $10.8B $15.1B $20.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.3B $4.1B $5.6B $7.5B $11.2B
Gross Profit $1.7B $3B $5.2B $7.6B $9.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $353M $590M $1.1B $1.8B $1.9B
Selling, General & Admin $1.1B $1.6B $2B $2.5B $3.2B
Other Inc / (Exp) -$43M -$109M -$198M -$615M -$182M
Operating Expenses $1.6B $2.6B $4.1B $5.4B $6.9B
Operating Income $128M $441M $1.1B $2.2B $2.6B
 
Net Interest Expenses $4M $91M $91M $39M $17M
EBT. Incl. Unusual Items $81M $241M $780M $1.6B $2.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $82M $149M $298M $569M $521M
Net Income to Company -$1M $83M $482M $987M $1.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$1M $83M $482M $987M $1.9B
 
Basic EPS (Cont. Ops) -$0.07 $1.69 $9.58 $19.67 $37.70
Diluted EPS (Cont. Ops) -$0.07 $1.69 $9.54 $19.54 $37.70
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $293M $674M $1.3B $2.3B $3.2B
EBIT $188M $470M $915M $1.7B $2.6B
 
Revenue (Reported) $4B $7.1B $10.8B $15.1B $20.8B
Operating Income (Reported) $128M $441M $1.1B $2.2B $2.6B
Operating Income (Adjusted) $188M $470M $915M $1.7B $2.6B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $7.1B $10.8B $15.1B $20.8B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.1B $5.6B $7.5B $11.2B --
Gross Profit $3B $5.2B $7.6B $9.6B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $590M $1.1B $1.8B $1.9B --
Selling, General & Admin $1.6B $2B $2.5B $3.2B --
Other Inc / (Exp) -$109M -$198M -$615M -$182M --
Operating Expenses $2.6B $4.1B $5.4B $6.9B --
Operating Income $441M $1.1B $2.2B $2.6B --
 
Net Interest Expenses $91M $91M $41M $20M --
EBT. Incl. Unusual Items $241M $780M $1.6B $2.4B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $149M $298M $569M $521M --
Net Income to Company $83M $482M $987M $1.9B --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $83M $482M $987M $1.9B --
 
Basic EPS (Cont. Ops) $1.69 $9.58 $19.67 $37.70 --
Diluted EPS (Cont. Ops) $1.69 $9.54 $19.54 $37.70 --
Weighted Average Basic Share $199.2M $201.4M $201.1M $202.8M --
Weighted Average Diluted Share $199.2M $203.4M $205.6M $202.8M --
 
EBITDA $674M $1.3B $2.3B $3.2B --
EBIT $470M $915M $1.7B $2.6B --
 
Revenue (Reported) $7.1B $10.8B $15.1B $20.8B --
Operating Income (Reported) $441M $1.1B $2.2B $2.6B --
Operating Income (Adjusted) $470M $915M $1.7B $2.6B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.9B $2.6B $1.9B $2.6B $2.6B
Short Term Investments $604.4M $208M $1.1B $1.2B $1.1B
Accounts Receivable, Net $49.7M $98M $130M $156M $255M
Inventory $118.1M $253M $152M $238M $296M
Prepaid Expenses $87.4M $94M $93M $87M $98M
Other Current Assets $13.4M $22M $30M $49M $51M
Total Current Assets $5.3B $8.2B $11B $14.3B $20.1B
 
Property Plant And Equipment $694.9M $1.3B $1.6B $2.1B $2.5B
Long-Term Investments $166.1M $76M $301M $139M $1.2B
Goodwill $85.2M $148M $153M $163M $149M
Other Intangibles $14.2M $45M $25M $35M $61M
Other Long-Term Assets $67.6M $140M $243M $67M $67M
Total Assets $6.5B $10.1B $13.7B $17.6B $25.2B
 
Accounts Payable $728.1M $1B $1.4B $2.1B $3.2B
Accrued Expenses $29.6M -- -- -- --
Current Portion Of Long-Term Debt $46.8M $1.1B $2.1B $2.2B $2.8B
Current Portion Of Capital Lease Obligations $62.6M $102M $156M $201M $282M
Other Current Liabilities $21.9M $23M $63M $53M $103M
Total Current Liabilities $3.6B $5.8B $8.6B $11.3B $16.6B
 
Long-Term Debt $844.6M $2.2B $2.6B $2.1B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $4.9B $8.6B $11.9B $14.5B $20.8B
 
Common Stock $50K -- -- -- --
Other Common Equity Adj -$468.3M -$515M -$464M -$290M -$920M
Common Equity $1.7B $1.5B $1.8B $3.1B $4.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.7B $1.5B $1.8B $3.1B $4.4B
 
Total Liabilities and Equity $6.5B $10.1B $13.7B $17.6B $25.2B
Cash and Short Terms $2.5B $2.8B $3B $3.8B $3.8B
Total Debt $1.4B $3.5B $4.7B $4.4B $5.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.9B $2.6B $1.9B $2.6B $2.6B
Short Term Investments $604.4M $208M $1.1B $1.2B $1.1B
Accounts Receivable, Net $49.7M $98M $130M $156M $255M
Inventory $118.1M $253M $152M $238M $296M
Prepaid Expenses $87.4M $94M $93M $87M $98M
Other Current Assets $13.4M $22M $30M $49M $51M
Total Current Assets $5.3B $8.2B $11B $14.3B $20.1B
 
Property Plant And Equipment $694.9M $1.3B $1.6B $2.1B $2.5B
Long-Term Investments $166.1M $76M $301M $139M $1.2B
Goodwill $85.2M $148M $153M $163M $149M
Other Intangibles $14.2M $45M $25M $35M $61M
Other Long-Term Assets $67.6M $140M $243M $67M $67M
Total Assets $6.5B $10.1B $13.7B $17.6B $25.2B
 
Accounts Payable $728.1M $1B $1.4B $2.1B $3.2B
Accrued Expenses $29.6M -- -- -- --
Current Portion Of Long-Term Debt $46.8M $1.1B $2.1B $2.2B $2.8B
Current Portion Of Capital Lease Obligations $62.6M $102M $156M $201M $282M
Other Current Liabilities $21.9M $23M $63M $53M $103M
Total Current Liabilities $3.6B $5.8B $8.6B $11.3B $16.6B
 
Long-Term Debt $844.6M $2.2B $2.6B $2.1B $2.8B
Capital Leases -- -- -- -- --
Total Liabilities $4.9B $8.6B $11.9B $14.5B $20.8B
 
Common Stock $50K -- -- -- --
Other Common Equity Adj -$468.3M -$515M -$464M -$290M -$920M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.7B $1.5B $1.8B $3.1B $4.4B
 
Total Liabilities and Equity $6.5B $10.1B $13.7B $17.6B $25.2B
Cash and Short Terms $2.5B $2.8B $3B $3.8B $3.8B
Total Debt $1.4B $3.5B $4.7B $4.4B $5.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$1M $83M $482M $987M $1.9B
Depreciation & Amoritzation $105M $204M $403M $524M $617M
Stock-Based Compensation $1M -- -- -- --
Change in Accounts Receivable -$510M -$1.1B -$1.2B -$1.4B -$2.7B
Change in Inventories -$107M -$142M $114M -$69M -$113M
Cash From Operations $1.2B $965M $2.9B $5.1B $7.9B
 
Capital Expenditures $247M $609M $455M $509M $860M
Cash Acquisitions -$7M -$56M -- -- -$6M
Cash From Investing -$252M -$1.6B -$3.9B -$3.5B -$8.3B
 
Dividends Paid (Ex Special Dividend) -$3M -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.4B $9.3B $17B $25B $19.5B
Long-Term Debt Repaid -$1.8B -$8.7B -$16B -$24.9B -$17.5B
Repurchase of Common Stock -$54M -$486M -$148M -$356M -$1M
Other Financing Activities -$307M $296M -- -- --
Cash From Financing $242M $1.9B $916M -$267M $2B
 
Beginning Cash (CF) $1.5B $2.5B $3.6B $3.4B $3.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2B $1.3B -$15M $1.4B $1.6B
Ending Cash (CF) $2.5B $3.6B $3.4B $3.8B $4.7B
 
Levered Free Cash Flow $935M $356M $2.5B $4.6B $7.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$50.9M -$46M $165M $165M $639M
Depreciation & Amoritzation $32.6M $67M $122M $135M $152M
Stock-Based Compensation $452K -- -$1M -- --
Change in Accounts Receivable -$209.9M -$465M -$360M -$1B -$1.2B
Change in Inventories -$66.7M -$28M $12M $16M -$3M
Cash From Operations $256M $701M $1.5B $1.9B $2.9B
 
Capital Expenditures $87.1M $155M $112M $180M $305M
Cash Acquisitions -$63K -$51M -- -- --
Cash From Investing $586.1M -$710M -$646M -$914M -$2.1B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $505.8M $3.2B $4.5B $5.6B $6.9B
Long-Term Debt Repaid -$371.7M -$2.4B -$4.5B -$5.5B -$6.1B
Repurchase of Common Stock -$14.3M -$46M -$33M -- --
Other Financing Activities -$120.2M -- -- -- --
Cash From Financing -$364K $2.3B -$12M $73M $757M
 
Beginning Cash (CF) $1.6B $1.4B $2.5B $3.3B $3.5B
Foreign Exchange Rate Adjustment $42.5M -$25M -$49M -$495M -$332M
Additions / Reductions $841.8M $2.3B $884M $1.1B $1.6B
Ending Cash (CF) $2.5B $3.6B $3.4B $3.8B $4.7B
 
Levered Free Cash Flow $168.9M $546M $1.4B $1.7B $2.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$1M $83M $482M $987M $1.9B
Depreciation & Amoritzation $105M $204M $403M $524M $617M
Stock-Based Compensation $1M -- -- -- --
Change in Accounts Receivable -$510M -$1.1B -$1.2B -$1.4B -$2.7B
Change in Inventories -$107M -$142M $114M -$69M -$113M
Cash From Operations $1.2B $965M $2.9B $5.1B $7.9B
 
Capital Expenditures $247M $609M $455M $509M $860M
Cash Acquisitions -$7M -$56M -- -- --
Cash From Investing -$252M -$1.6B -$3.9B -$3.5B -$8.3B
 
Dividends Paid (Ex Special Dividend) -$3M -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.4B $9.3B $17B $25B $19.5B
Long-Term Debt Repaid -$1.8B -$8.7B -$16B -$24.9B -$17.5B
Repurchase of Common Stock -$54M -$486M -$148M -$356M -$1M
Other Financing Activities -- $296M -- -- --
Cash From Financing $242M $1.9B $916M -$267M $2B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2B $1.3B -$15M $1.4B $1.6B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $935M $356M $2.5B $4.6B $7.1B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $83M $482M $987M $1.9B --
Depreciation & Amoritzation $204M $403M $524M $617M --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.1B -$1.2B -$1.4B -$2.7B --
Change in Inventories -$142M $114M -$69M -$113M --
Cash From Operations $965M $2.9B $5.1B $7.9B --
 
Capital Expenditures $609M $455M $509M $860M --
Cash Acquisitions -$56M -- -- -- --
Cash From Investing -$1.6B -$3.9B -$3.5B -$8.3B --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $9.3B $17B $25B $19.5B --
Long-Term Debt Repaid -$8.7B -$16B -$24.9B -$17.5B --
Repurchase of Common Stock -$486M -$148M -$356M -$1M --
Other Financing Activities $296M -- -- -- --
Cash From Financing $1.9B $916M -$267M $2B --
 
Beginning Cash (CF) $6.6B $10.8B $14B $15B --
Foreign Exchange Rate Adjustment -$153M -$270M -$938M -$739M --
Additions / Reductions $1.3B -$15M $1.4B $1.6B --
Ending Cash (CF) $7.7B $10.6B $14.5B $15.8B --
 
Levered Free Cash Flow $356M $2.5B $4.6B $7.1B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will SoundHound AI Stock Recover?
Will SoundHound AI Stock Recover?

SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…

What Stocks Did Warren Buffett Just Buy?
What Stocks Did Warren Buffett Just Buy?

In Q4 of last year, Warren Buffett added to or…

Is it Finally Time to Buy Medical Properties Trust?
Is it Finally Time to Buy Medical Properties Trust?

Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
85
SLNO alert for Mar 29

Soleno Therapeutics [SLNO] is up 6.8% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock